(Q34307573)

1 August 2017

1 reference

title

Clostridia in cancer therapy (English)

1 reference

1 August 2017

Nigel P Minton

1

0 references

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Nature Reviews Microbiology

1 August 2017

1 reference

1 August 2017

1

1 reference

1 August 2017

237-242

1 reference

1 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro777

1 August 2017

0 references

cites work

Antibody directed enzymes revive anti-cancer prodrugs concept

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Viruses in therapy--royal road or dead end?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Gene therapy progress and prospects: adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Conditionally replicating viruses in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Tissue-dependent factors affect gene delivery to tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Hypoxia-mediated tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Effect of Histolyticus Infection and Toxin on Transplantable Mouse Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Chemotherapeutic tumour targeting using clostridial spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--I. Purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Combination bacteriolytic therapy for the treatment of experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Bacillus amyloliquefaciens orthologue of Bacillus subtilis ywrO encodes a nitroreductase enzyme which activates the prodrug CB 1954.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Gene-Directed Enzyme Prodrug Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Hypoxia-inducible factor 1: master regulator of O2 homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Chemotherapeutic tumour targeting using clostridial spores

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Metabolic studies with 5-fluorocytosine-6-14C in mouse, rat, rabbit, dog and man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO777

31 March 2020

Identifiers

DOI

10.1038/NRMICRO777

1 reference

PubMed ID

15035028

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

15035028